CD274 and cancer: Our results revealed that extracellular REIC/Dkk-3 protein makes PD-L1 break away from the chemokine receptors that sequester PD-L1 in the cytoplasmic compartment, leading to an accelerated degradation of PD-L1; cancer immune evasion is thereby dampened.